Eli Lilly and Company

Activity from announced rounds

Activity in this selectionUnited States · Oct 14, 2026 · Sep 15, 2026
Rounds participated in
3
Confirmed lead rounds
0
All roles disclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$320.5M
3 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1
Undisclosed1

By primary sector

Healthtech2
Biotech1

By country

United States3

Rounds

3 in this selection
General Medicine

An online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.

$120MSeries B
Participant
Thatch

A health-benefits platform that lets employers set healthcare budgets while employees choose insurance and eligible care to fit their needs.

$108MNew funding
Participant
Circle Pharma, Inc.

Circle Pharma discovers macrocycle medicines for cancer and other serious diseases using its MXMO platform, which combines computational, structure-based design with synthetic chemistry to create cell-permeable compounds against difficult protein targets. Its lead programs are investigational and at discovery or preclinical stages.

$92.5MSeries E
Participant